Xiao W, Xu C
Oncol Lett. 2024; 28(5):521.
PMID: 39268159
PMC: 11391256.
DOI: 10.3892/ol.2024.14654.
Razi S, Haghparast A, Chodari Khameneh S, Sadrabadi A, Aziziyan F, Bakhtiyari M
Cell Commun Signal. 2023; 21(1):143.
PMID: 37328876
PMC: 10273768.
DOI: 10.1186/s12964-023-01129-w.
Lendeckel U, Karimi F, Al Abdulla R, Wolke C
Biomedicines. 2023; 11(3).
PMID: 36979703
PMC: 10045183.
DOI: 10.3390/biomedicines11030724.
Schultz C, Nevler A
Biomedicines. 2022; 10(12).
PMID: 36552005
PMC: 9775650.
DOI: 10.3390/biomedicines10123249.
Lendeckel U, Wolke C
Biomedicines. 2022; 10(10).
PMID: 36289675
PMC: 9598867.
DOI: 10.3390/biomedicines10102413.
Antitumor Effect of Si-Jun-Zi Decoction on SGC7901 Gastric Cancer Cells by CMTM2 Activation.
Li X, Chen W, Miao L, Sun H, Gao X, Guo S
Evid Based Complement Alternat Med. 2022; 2022:4675815.
PMID: 35873650
PMC: 9303151.
DOI: 10.1155/2022/4675815.
Comprehensive Analysis of VCAN Expression Profiles and Prognostic Values in HCC.
Sun G, Zheng W, Tan P, Zhou J, Tang W, Cao H
Front Genet. 2022; 13:900306.
PMID: 35812745
PMC: 9263583.
DOI: 10.3389/fgene.2022.900306.
Molecular mechanism of therapeutic approaches for human gastric cancer stem cells.
Hsieh H, Yu M, Cheng L, Yeh T, Tsai M
World J Stem Cells. 2022; 14(1):76-91.
PMID: 35126829
PMC: 8788185.
DOI: 10.4252/wjsc.v14.i1.76.
Immunotherapy for targeting cancer stem cells in hepatocellular carcinoma.
Dai X, Guo Y, Hu Y, Bao X, Zhu X, Fu Q
Theranostics. 2021; 11(7):3489-3501.
PMID: 33537099
PMC: 7847682.
DOI: 10.7150/thno.54648.
FOLFOX Therapy Induces Feedback Upregulation of CD44v6 through YB-1 to Maintain Stemness in Colon Initiating Cells.
Ghatak S, Hascall V, Markwald R, Misra S
Int J Mol Sci. 2021; 22(2).
PMID: 33451103
PMC: 7828641.
DOI: 10.3390/ijms22020753.
Heteromeric Solute Carriers: Function, Structure, Pathology and Pharmacology.
Fairweather S, Shah N, Brer S
Adv Exp Med Biol. 2020; 21:13-127.
PMID: 33052588
DOI: 10.1007/5584_2020_584.
SATB2 is a novel biomarker and therapeutic target for cancer.
Roy S, Shrivastava A, Srivastav S, Shankar S, Srivastava R
J Cell Mol Med. 2020; 24(19):11064-11069.
PMID: 32885593
PMC: 7576221.
DOI: 10.1111/jcmm.15755.
Expression profiling revealed keratins and interleukins as potential biomarkers in squamous cell carcinoma of horn in Indian bullocks ().
Panchal K, Koringa P, Sabara P, Bhatia D, Jakhesara S, Joshi C
3 Biotech. 2020; 10(3):92.
PMID: 32089987
PMC: 7000593.
DOI: 10.1007/s13205-020-2078-9.
Proteomic Level Changes on Treatment in MCF-7/DDP Breast Cancer Drug- Resistant Cells.
Jin G, Wang K, Liu Y, Liu X, Zhang X, Zhang H
Anticancer Agents Med Chem. 2020; 20(6):687-699.
PMID: 32053082
PMC: 7403652.
DOI: 10.2174/1871520620666200213102849.
Higher expression of SATB2 in hepatocellular carcinoma of African Americans determines more aggressive phenotypes than those of Caucasian Americans.
Yu W, Roy S, Ma Y, LaVeist T, Shankar S, Srivastava R
J Cell Mol Med. 2019; 23(12):7999-8009.
PMID: 31602781
PMC: 6850930.
DOI: 10.1111/jcmm.14652.
The Non-Essential Amino Acid Cysteine Becomes Essential for Tumor Proliferation and Survival.
Combs J, DeNicola G
Cancers (Basel). 2019; 11(5).
PMID: 31100816
PMC: 6562400.
DOI: 10.3390/cancers11050678.
Prognostic significance of tumor immune microenvironment and immunotherapy: Novel insights and future perspectives in gastric cancer.
Lazar D, Avram M, Romosan I, Cornianu M, Taban S, Goldis A
World J Gastroenterol. 2018; 24(32):3583-3616.
PMID: 30166856
PMC: 6113718.
DOI: 10.3748/wjg.v24.i32.3583.
Chemopreventive activity of celastrol in drug-resistant human colon carcinoma cell cultures.
Moreira H, Szyjka A, Gasiorowski K
Oncotarget. 2018; 9(30):21211-21223.
PMID: 29765532
PMC: 5940375.
DOI: 10.18632/oncotarget.25014.
Evaluation of the effect of hyperthermia and electron radiation on prostate cancer stem cells.
Rajaee Z, Khoei S, Mahdavi S, Ebrahimi M, Shirvalilou S, Mahdavian A
Radiat Environ Biophys. 2018; 57(2):133-142.
PMID: 29453555
DOI: 10.1007/s00411-018-0733-x.
Modified miR-15a has therapeutic potential for improving treatment of advanced stage colorectal cancer through inhibition of BCL2, BMI1, YAP1 and DCLK1.
Fesler A, Liu H, Ju J
Oncotarget. 2018; 9(2):2367-2383.
PMID: 29416778
PMC: 5788646.
DOI: 10.18632/oncotarget.23414.